Eversource Energy Completes the Sale of Aquarion Water Company

Eversource (ES) completed the $2.4B cash sale of Aquarion Water Company to the Aquarion Water Authority, generating ~$1.7B of adjusted net equity proceeds to reduce debt and strengthen its balance sheet. The deal is expected to drive an after-tax, non-cash, non-recurring charge of ~$115M (about $0.31/share) in Q2 2026, while revised 2026 non-GAAP EPS guidance is $4.57 to $4.72 (reflecting the absence of Aquarion earnings). Management reaffirmed long-term EPS growth of 5–7% through 2030, using $4.65 as the 2026 midpoint baseline.

Analysis

This is less an earnings event than a capital-structure de-risking. For ES, the immediate upside is lower equity risk premium and better refinancing optionality; the lost water earnings matter less than the signaling effect that management is willing to shrink the asset base to protect the credit profile. Over the next 1-3 months, the key catalyst is whether rating agencies acknowledge the deleveraging and whether ES can frame the remaining business as a cleaner regulated platform with lower funding cost.

Second-order, the beneficiary set extends beyond ES common equity: ES debt and any downstream paper linked to its balance sheet should tighten first, while the broader utility complex may see a modest multiple benefit if investors re-price "simplification" as a credit-positive path. The loser is any diversified utility trading on a conglomerate discount with non-core assets still embedded; this deal makes the market more sensitive to peers that have not cleaned up the story. The main caveat is that this is not free EPS growth — the recurring earnings base steps down, so the stock only earns a higher multiple if lower leverage and lower interest expense offset the missing contribution.

Contrarian view: the consensus may be overcalling this as a structural rerate when it is mostly a balance-sheet repair trade. If ES does not show a visible decline in net debt / EBITDA or if FERC / rate-case noise keeps compressing allowed returns, the stock can give back the initial pop. The thesis is most vulnerable if rates back up or if management is forced to redirect proceeds into capex instead of debt reduction, which would blunt the credit story.

Key Decisions for Investors

• Long ES vs XLU for 1-3 months: express the view that ES should outperform the utility basket on credit de-risking alone; stop if ES fails to outperform XLU by ~3% after the first 2-3 weeks or if utility rates spike and compress the whole sector.
• Buy ES on any post-close weakness over the next 1-5 trading days, targeting a modest rerating rather than a trend move; the best setup is if management or the agencies confirm lower leverage within the next quarter.
• Watchlist, not a trade yet: ES debt and credit spreads for the next 30-60 days. If spreads do not tighten or if ratings guidance remains unchanged, treat the event as largely cosmetic and fade any equity rally.
• Avoid chasing the headline into a broad utility long; prefer ES-specific exposure because the upside is idiosyncratic, while XLU still carries rate-duration risk and no comparable balance-sheet catalyst.
• If ES rallies sharply on the print, consider reducing or hedging with a short XLU overlay; the market may be pricing a rerating before the cash flow benefit is visible in 2026-2027 numbers.